Grantham, Mayo, Van Otterloo & Co. LLC
Position in FOLD — AMICUS THERAPEUTICS, INC.
CIK 1352662
Boston, MA
Position in FOLD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$13,610,706
New position
Shares Held
941,266
first reported quarter
Ownership
0.300%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $93,420,610 across 9 Biotechnology names. FOLD ranks #3 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
55,353 | $42,767,941 | |
| 2 | INCY |
Incyte Corp
|
364,657 | $34,321,516 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
941,266 | $13,610,706 | |
| 4 | EXEL |
Exelixis, Inc.
|
38,235 | $1,639,899 | |
| 5 | ALT |
Altimmune, Inc.
|
126,389 | $389,278 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
11,182 | $313,207 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
|
15,444 | $206,486 | |
| 8 | VNDA |
Vanda Pharmaceuticals Inc.
|
16,322 | $112,785 |
All Filings in FOLD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,610,706 | 941,266 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||